GlassScriptPhysician profile
Victor T Chen
NPI 1356342901
$5,168.22
in general payments reported to CMS, 2019-2025
28 companies · $445 in 2025
The $445 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $259 · 2021: $333 · 2022: $2,237 · 2023: $303 · 2024: $539 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,044 · Gift: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.10 |
| Gift | $243.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $1,608.00 | 2022 | |
| Intuitive Surgical, INC. | $1,155.25 | 2019-2024 | |
| Hologic Sales and Service, LLC | $446.79 | 2020-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Abbvie INC. | $366.85 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $154.78 | 2019-2023 | |
| Myovant Sciences INC. | $146.91 | 2022 | |
| Caldera Medical, INC | $142.89 | 2022 | |
| Merck Sharp & Dohme LLC | $140.86 | 2019-2024 | Gardasil 9, Gardasil |
| Applied Medical Resources Corporation | $107.01 | 2022-2023 | |
| Aspira Women'S Health INC | $98.57 | 2022 | |
| Coopersurgical, INC. | $93.06 | 2019-2025 | Paragard T 380a, Summit Doppler |
| Sumitomo Pharma America, INC. | $83.63 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $67.39 | 2020-2022 | |
| Boston Scientific Corporation | $63.01 | 2023-2024 | Capio Rp, Upsylon, Solyx Sis System |
| Astellas Pharma US INC | $62.66 | 2023-2025 | Veozah, Myrbetriq |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $62.29 | 2019-2020 | |
| Therapeuticsmd, INC. | $54.06 | 2019-2021 | |
| Exeltis, USA INC. | $51.31 | 2020-2021 | |
| Biogen, INC. | $49.09 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $39.47 | 2021 | |
| Organon LLC | $36.88 | 2023-2025 | Nexplanon |
| Davol INC. | $31.35 | 2025 | Arista |
| Medtronic, INC. | $22.48 | 2022 | |
| Gynesonics, INC. | $22.04 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $17.49 | 2025 | Pico 14, Pico 7 |
| Baxter Healthcare | $15.69 | 2024 | Perclot |
| Pfizer INC. | $14.48 | 2024 | |
| Evofem Biosciences, INC. | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.